The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Open accessAbstract
Physiologic osteoclast renewal results from the differentiation of bone marrow monocytes (BMMs) into osteoclasts, a process induced by the simultaneous stimulation of osteoclast precursors by macrophage colonystimulating factor (M-CSF) and a TNF-related factor known as receptor activator of NF-κB ligand (RANKL; also known as OPGL, TRANCE, or ODF) (1-3).Although upregulation of osteoclast formation is recognized as the main mechanism by which estrogen deficiency induces bone loss (4, 5), the responsible cells and cytokines are not completely understood.Bone marrow stromal cells are essential for physiologic osteoclast renewal because they represent a major source of RANKL and M-CSF and provide a physical support for nascent osteoclasts (6).However, in stimulated conditions additional bone marrow cells contribute to regulate osteoclast formation by producing soluble and membrane-bound pro-and antiosteoclastogenic cytokines.Among them are activated T cells, which stimulate osteoclast formation through increased production of RANKL, a phenomenon that contributes to inflammation-induced bone loss (7).T cells express estrogen receptors, and estrogen directly regulates T-cell function and cytokine production (8-11).Moreover, T-cell subset alterations occur in women with postmenopausal osteoporosis (12, 13).Taken together, these findings suggest that T cells may contribute to enhanced osteoclast formation and induce bone loss not only during inflammation, but also in conditions of estrogen deficiency.In this study we have investigated the role of T cells in ovariectomy-induced bone loss.We report that ovariectomy-enhanced T-cell production of TNF-α, which, acting through the TNF-α receptor p55, augments M-CSF-and RANKL-induced osteoclastogenesis.We also show that ovariectomy failed to induce bone loss, stimulate bone resorption, and increase osteoclast formation in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. Methods Experimental protocol.All animal procedures were approved by the Animal Care and Use Committee of Barnes-Jewish Hospital.Wild-type C57BL/6 mice, C57BL/6 homozygous (nu/nu) athymic nude mice (14), and heterozygous (nu/+) euthymic control littermates were obtained from Taconic Farms Inc. (Germantown, New York, USA).C57BL/6 mice lacking either TNF-α receptor 1 (p55 -/-) or TNF-α receptor II (p75 -/-) and wild-type controls of the same genetic background were obtained from Jackson Laboratories (Bar Harbor, Maine, USA).At 5 weeks of age mice were either sham operated or ovariectomized (OVX), and either left untreated or treated with 17β estradiol (0.16 µg/d) for 4 weeks as described (15,16).In vitro osteoclast generation, cytokine neutralization, and TNF-α assay.Bone marrow cells were either cultured unfractionated or depleted of stromal cells by adherence for 12 hours.The nonadherent fraction was used as a source of T cells and BMM precursors and was found to
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, estrogen inhibits osteoclast formation by reducing the levels of other osteoclastogenic cytokines such as IL-1, IL-6, IL-11, TNF-α, TNF-β, and M-CSF [160, 161].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [161]
In the citing paper
“We proposed that T cell-produced TNF is required for ovxinduced bone loss based on the findings that no bone loss occurred and no increased TNF production was detected in T cell-null mice or mice depleted of T cells (40,53).”
From Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics (2016) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,309
Bone histomorphometry : techniques and interpretation
Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,160
Research works printed but not linked: 2
- Olsen, 1996, Endocr Rev, 17, 369
- Fujita, 1984, Miner Electrolyte Metab, 10, 375
Cited by
Sorted by citations
Items 101–200 of 703
Robbie‐Ryan, M., Shepherd, R., Leavey, J. K., Gao, Y., Grassi, F., Schnell, F. J., Qian, W., Kersh, G. J., Weitzmann, M. N., & Pacifici, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505168102 · Cited by 136
Self-citationKarsdal, M. A., Hjorth, P., Henriksen, K., Kirkegaard, T., Nielsen, K. L., Lou, H., Delaissé, J., & Foged, N. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303905200 · Cited by 137
Aoki, K., Saito, H., Itzstein, C., Ishiguro, M., Shibata, T., Blanqué, R., Mian, A. H., Takahashi, M., Suzuki, Y., Yoshimatsu, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22513 · Cited by 136
Lu, X., Gilbert, L. C., He, X., Rubin, J. E., & Nanes, M. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507804200 · Cited by 135
Qiu, S., Vazquez, J. T., Boulger, E., Liu, H., Xue, P., Hussain, M. A., & Wolfe, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01937-4 · Cited by 135
Liao, L., Su, X., Yang, X., Hu, C., Li, B., Lv, Y., Shuai, Y., Jing, H., Deng, Z., & Jin, Y. J. (2015) · Stem Cells · doi:10.1002/stem.2274 · Cited by 135
Regulatory roles and molecular signaling of TNF family members in osteoclasts
Feng, X. (2005) · Gene · doi:10.1016/j.gene.2005.01.014 · Cited by 132
Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bhattarai, H. K., Shrestha, S., Rokka, K., & Shakya, R. (2020) · Journal of Osteoporosis · doi:10.1155/2020/9324505 · Cited by 140
Therapy-Induced Senescence Drives Bone Loss
Yao, Z., Murali, B., Ren, Q., Luo, X., Faget, D. V., Cole, T., Ricci, B., Thotala, D., Monahan, J., van Deursen, J. M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2348 · Cited by 129
Molecular and Cellular Mechanisms of Osteoporosis
Zhivodernikov, I. V., Kirichenko, T. V., Markina, Y. V., Postnov, A. Y., & Markin, A. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115772 · Cited by 149
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
DeSelm, C. J., Takahata, Y., Warren, J. T., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24165 · Cited by 132
Farr, J. N., Rowsey, J. L., Eckhardt, B. A., Thicke, B. S., Fraser, D. G., Tchkonia, T., Kirkland, J. L., Monroe, D. G., & Khosla, S. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3729 · Cited by 127
Estrogens in rheumatoid arthritis; the immune system and bone
Islander, U., Jochéms, C., Lagerquist, M. K., Forsblad‐d’Elia, H., & Carlsten, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.018 · Cited by 129
McNamara, L. M. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0282 · Cited by 124
Gilbert, L. C., Rubin, J. E., & Nanes, M. S. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00534.2004 · Cited by 124
Lee, C., Kim, J., & Jung, Y. (2019) · Cells · doi:10.3390/cells8101259 · Cited by 128
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.
Udagawa, N., Kotake, S., Kamatani, N., Takahashi, N., & Suda, T. (2002) · Arthritis Research · doi:10.1186/ar431 · Cited by 121
Maccarrone, M., Bari, M., Battista, N., & Finazzi‐Agrò, A. (2002) · Blood · doi:10.1182/blood-2002-05-1444 · Cited by 122
Rosillo, M. Á., Alcaraz, M. J., Sánchéz‐Hidalgo, M., Fernández‐Bolaños, J. G., Alarcón‐de‐la‐Lastra, C., & Ferrándiz, M. L. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.07.006 · Cited by 121
Taler, M., Gil‐Ad, I., Lomnitski, L., Korov, I., Baharav, E., Bar, M., Zolokov, A., & Weizman, A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.010 · Cited by 121
Wang, L., Liu, S., Zhao, Y., Liu, D., Liu, Y., Chen, C., Karray, S., Shi, S., & Jin, Y. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.14 · Cited by 120
Parikka, V., Lehenkari, P. P., Sassi, M.-L., Halleen, J. M., Risteli, J., Härkönen, P. L., & Väänänen, H. K. (2001) · Endocrinology · doi:10.1210/endo.142.12.8533 · Cited by 118
Inflammatory Osteoclasts Prime TNFα-Producing CD4+ T Cells and Express CX3CR1
Ibáñez, L., Abou-Ezzi, G., Ciucci, T., Amiot, V., Belaïd, N., Obino, D., Mansour, A., Rouleau, M., Wakkach, A., & Blin-Wakkach, C. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2868 · Cited by 117
Sex Differences in Destructive Periodontal Disease: Exploring the Biologic Basis
Shiau, H. J., & Reynolds, M. A. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.100045 · Cited by 125
Gut microbiota and bone metabolism
Lu, L., Chen, X., Liu, Y., & Yu, X. (2021) · The FASEB Journal · doi:10.1096/fj.202100451r · Cited by 127
Mouse Mandible Contains Distinctive Mesenchymal Stem Cells
Yamaza, T., Ren, G., Akiyama, K., Chen, C., Shi, Y., & Shi, S. (2010) · Journal of Dental Research · doi:10.1177/0022034510387796 · Cited by 115
Pacifici, R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.027 · Cited by 120
Self-citationHikiji, H., Takato, T., Shimizu, T., & Ishii, S. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.003 · Cited by 114
Bone diseases in patients with chronic liver disease
Jeong, H., & Kim, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174270 · Cited by 113
Amelioration of rat adjuvant‐induced arthritis by Met‐RANTES
Shahrara, S., Proudfoot, A. E. I., Woods, J. M., Ruth, J. H., Amin, M. A., Park, C. C., Haas, C. S., Pope, R. M., Haines, G. K., Zha, Y. Y., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21033 · Cited by 113
Grant, P., Kitch, D. W., McComsey, G. A., Dubé, M. P., Haubrich, R., Huang, J. S., Riddler, S. A., Tebas, P., Zolopa, A. R., Collier, A. C., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit538 · Cited by 112
Estrogen Regulation of Endothelial and Smooth Muscle Cell Migration and Proliferation
Geraldes, P., Sirois, M. G., Bernatchez, P. N., & Tanguay, J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000035393.11854.6a · Cited by 112
Schaller, S., Henriksen, K., Høegh-Andersen, P., Søndergaard, B. C., Sumer, E. U., Tankó, L. B., Qvist, P., & Karsdal, M. A. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.553 · Cited by 113
Li, L., Rao, S., Cheng, Y., Zhuo, X., Deng, C., Xu, N., Zhang, H., & Yang, L. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.810 · Cited by 109
“Modulation of mouse RANKL gene expression by Runx2 and vita‐ min D3.”
BackgroundInfluentialIL-7 Up-Regulates TNF-α-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor
Roato, I., Brunetti, G., Gorassini, E., Grano, M., Colucci, S., Bonello, L., Buffoni, L., Manfredi, R., Ruffini, E., Ottaviani, D., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000124 · Cited by 125
The immune system, bone and RANKL
Guerrini, M. M., & Takayanagi, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.003 · Cited by 116
From osteoimmunology to osteomicrobiology: How the microbiota and the immune system regulate bone
Hsu, E., & Pacifici, R. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0321-0 · Cited by 106
Self-citationEstrogen signaling impacts temporomandibular joint and periodontal disease pathology
Robinson, J. L., Johnson, P. M., Kister, K., Yin, M. T., Chen, J., & Wadhwa, S. (2019) · Odontology · doi:10.1007/s10266-019-00439-1 · Cited by 106
Bench-to-bedside strategies for osteoporotic fracture: From osteoimmunology to mechanosensation
Xie, Y., Zhang, L., Xiong, Q., Gao, Y., Ge, W., & Tang, P. (2019) · Bone Research · doi:10.1038/s41413-019-0066-7 · Cited by 107
T Lymphocyte–Deficient Mice Lose Trabecular Bone Mass With Ovariectomy
Lee, S., Kadono, Y., Okada, F., Jacquin, C., Koczon-Jaremko, B., Gronowicz, G., Adams, D. J., Aguila, H. L., Choi, Y., & Lorenzo, J. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060726 · Cited by 106
Ibáñez, L., Rouleau, M., Wakkach, A., & Blin-Wakkach, C. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.02.008 · Cited by 103
Rifas, L. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20933 · Cited by 103
Immune responses and bone loss: the estrogen connection
Carlsten, H. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00326.x · Cited by 104
Bone Remodeling and the Microbiome
Pacifici, R. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031203 · Cited by 101
Self-citationBu, S. Y., Hunt, T. S., & Smith, B. J. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.11.012 · Cited by 99
Rifas, L., & Weitzmann, M. N. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24877 · Cited by 96
Self-citationOfotokun, I., McIntosh, E. B., & Weitzmann, M. N. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0099-z · Cited by 99
Self-citationHigh dose M‐CSF partially rescues the Dap12−/− osteoclast phenotype
Faccio, R., Zou, W., Colaianni, G., Teitelbaum, S. L., & Ross, F. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10694 · Cited by 98
Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link
Sapir‐Koren, R., & Livshits, G. (2017) · Bone · doi:10.1016/j.bone.2017.06.020 · Cited by 99
Ofotokun, I., Titanji, K., Vunnava, A., Roser-Page, S., Vikulina, T., Villinger, F., Rogers, K., Sheth, A., Lahiri, C. D., Lennox, J., et al. (2016) · AIDS (London) · doi:10.1097/qad.0000000000000918 · Cited by 94
Self-citationVural, P., Akgül, C., & Canbaz, M. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.06.006 · Cited by 94
T cells: Critical bone regulators in health and disease
Pacifici, R. (2010) · Bone · doi:10.1016/j.bone.2010.04.611 · Cited by 98
Self-citationZhao, R. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.5180 · Cited by 94
Fitzpatrick, L. A., Buzás, E. I., Gagne, T. J., Nagy, A., Horvath, C., Ferencz, V., Mester, A., Kari, B., Ruan, M., Falus, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0934373100 · Cited by 92
Estrogen Regulation of Immune Cell Bone Interactions
Weitzmann, M. N., & Pacifici, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.030 · Cited by 92
Self-citationMa, Y., Nyman, J. S., Tao, H., Moss, H. H., Yang, X., & Elefteriou, F. (2011) · Endocrinology · doi:10.1210/en.2010-0881 · Cited by 92
Scott, M. B., Styring, A., & McCullagh, J. (2022) · Pathogens · doi:10.3390/pathogens11070770 · Cited by 98
Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss
Tawfeek, H. A. W., Bedi, B., Li, J., Adams, J., Kobayashi, T., Weitzmann, M. N., Kronenberg, H. M., & Pacifici, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012290 · Cited by 92
Self-citationAttenuation of osteoclastogenesis and osteoclast function by apigenin
Bandyopadhyay, S., Lion, J.-M., Mentaverri, R., Ricupero, D. A., Kamel, S., Romero, J. R., & Chattopadhyay, N. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.018 · Cited by 92
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Jones, D. C., Glimcher, L. H., & Aliprantis, A. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46262 · Cited by 93
T Cells Are Required for Orthodontic Tooth Movement
Yan, Y., Liu, F., Kou, X., Liu, D., Yang, R., Wang, X., Song, Y., He, D., Gan, Y.-H., & Zhou, Y. (2015) · Journal of Dental Research · doi:10.1177/0022034515595003 · Cited by 92
Li, J., Ding, Z., Li, Y., Wang, W., Wang, J., Yu, H., Liu, A., Miao, J., Chen, S., Wu, T., et al. (2019) · Journal of Orthopaedic Research® · doi:10.1002/jor.24497 · Cited by 88
Weitzmann, M. N., & Pacifici, R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.068 · Cited by 88
Self-citationGH/IGF-I and bone resorption in vivo and in vitro
Ueland, T. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01874 · Cited by 88
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87
“Osteoporosis is a pro-inflammatory state with increased inflammatory cytokines and activated T-cells [19].”
Immune changes in post-menopausal osteoporosis: the Immunos study
Breuil, V., Ticchioni, M., Testa, J., Roux, C. H., Ferrari, P. P., Breittmayer, J. P., Albert-Sabonnadière, C., Durant, J., Perreti, F. D., Bernard, A., et al. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1018-7 · Cited by 88
Role of T cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss
Ofotokun, I., Titanji, K., Vikulina, T., Roser-Page, S., Yamaguchi, M., Zayzafoon, M., Williams, I., & Weitzmann, M. (2015) · Nature Communications · doi:10.1038/ncomms9282 · Cited by 78
Self-citationAdvances in Probiotic Regulation of Bone and Mineral Metabolism
McCabe, L. R., & Parameswaran, N. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0403-7 · Cited by 85
Sui, B., Chen, J., Zhang, X., He, T., Zhao, P., Zheng, C., Li, M., Hu, C., & Jin, Y. J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0192-0 · Cited by 86
Víctor, V. M., & Rocha, M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780363077 · Cited by 85
Mercuri, L. G. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.03.056 · Cited by 84
Lombardi, G., Ziemann, E., & Banfi, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00060 · Cited by 92
Cheung, J., Mak, Y. T., Papaioannou, S., Evans, B. A., Fogelman, I., & Hampson, G. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770423 · Cited by 83
Oral bovine lactoferrin improves bone status of ovariectomized mice
Blais, A., Malet, A., Mikogami, T., Martin‐Rouas, C., & Tomé, D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90938.2008 · Cited by 82
Protective role of n-3 lipids and soy protein in osteoporosis
Fernandes, G., Lawrence, R. A., & Sun, D. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00060-7 · Cited by 81
Lu, X., FARMER, P. K., Rubin, J. E., & Nanes, M. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20143 · Cited by 80
Gut Microbiota and Bone Diseases: A Growing Partnership
Chen, Y., Wang, X., Zhang, C., Liu, Z., Li, C., & Ren, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.877776 · Cited by 87
Runx2 in human breast carcinoma: its potential roles in cancer progression
Onodera, Y., Miki, Y., Suzuki, T., Takagi, K., Akahira, J., Sakyu, T., Watanabe, M., Inoue, S., Ishida, T., Ohuchi, N., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01742.x · Cited by 78
Yun, A. J., & Lee, P. Y. (2004) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00326-8 · Cited by 76
Osteomicrobiology: The influence of gut microbiota on bone in health and disease
Jones, R. M., Mullé, J. G., & Pacifici, R. (2017) · Bone · doi:10.1016/j.bone.2017.04.009 · Cited by 79
Self-citationInflammation and gut dysbiosis as drivers of CKD–MBD
Evenepoel, P., Stenvinkel, P., Shanahan, C. M., & Pacifici, R. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00736-7 · Cited by 82
Self-citationT-cells and B-cells in osteoporosis
Weitzmann, M. N. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000103 · Cited by 74
Self-citationEstrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders
Crider, A., & Pillai, A. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237412 · Cited by 76
Osteoclasts—Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0011-2015 · Cited by 80
Self-citationRosillo, M. Á., Sánchéz‐Hidalgo, M., González‐Benjumea, A., Fernández‐Bolaños, J. G., Lubberts, E., & Alarcón‐de‐la‐Lastra, C. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500304 · Cited by 73
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
Ming, J., Cronin, S. J. F., & Penninger, J. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01283 · Cited by 75
Rendina-Ruedy, E., Hembree, K. D., Davis, M. R., Marlow, D. D., Clarke, S. L., Halloran, B. P., Lucas, E. A., & Smith, B. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060569 · Cited by 71
Probiotics in Gut-Bone Signaling
Schepper, J. D., Irwin, R., Kang, J., Dagenais, K., Lemon, T., Shinouskis, A., Parameswaran, N., & McCabe, L. R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66653-2_11 · Cited by 76
Obesity-induced inflammation: The impact of the hematopoietic stem cell niche
Bowers, E., & Singer, K. (2021) · JCI Insight · doi:10.1172/jci.insight.145295 · Cited by 72
The G-Protein-Coupled Receptor GPR103 Regulates Bone Formation
Baribault, H., Danao, J., Gupte, J., Li, Y., Sun, B., Richards, W. G., & Tian, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.709-717.2006 · Cited by 70
Estrogens as regulator of hematopoietic stem cell, immune cells and bone biology
Kumar, R. S., & Goyal, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119091 · Cited by 73
Yang, X., Zhou, F., Yuan, P., Dou, G., Liu, X., Liu, S., Wang, X., Jin, R., Dong, Y., Zhou, J., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.034 · Cited by 69
TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition
Kim, B., Bae, S. J., Lee, S.-Y., Lee, Y., Baek, J., Park, S., Lee, S. H., Koh, J., & Kim, G. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.100 · Cited by 69
Lu, X., Beck, G. R., Gilbert, L. C., Camalier, C. E., Bateman, N. W., Hood, B. L., Conrads, T. P., Kern, M. J., You, S., Chen, H., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.203 · Cited by 72
Rendina-Ruedy, E., Lim, Y., Marlow, D. D., Wang, Y., Clarke, S. L., Kuvibidila, S. R., Lucas, E. A., & Smith, B. J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.010 · Cited by 68
Genetic Responses to Nanostructured Calcium-phosphate-coated Implants
Jimbo, R., Xue, Y., Hayashi, M. K., Filho, H. O. S., Andersson, M., Mustafa, K., & Wennerberg, A. (2011) · Journal of Dental Research · doi:10.1177/0022034511422911 · Cited by 68
Wang, Q., Khan, N. A., Muthumalage, T., Lawyer, G. R., McDonough, S. R., Chuang, T., Gong, M., Sundar, I. K., Rehan, V. K., & Rahman, I. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00048 · Cited by 68
Monosodium Glutamate-Sensitive Hypothalamic Neurons Contribute to the Control of Bone Mass
Elefteriou, F., Takeda, S., Liu, X., Armstrong, D. L., & Karsenty, G. (2003) · Endocrinology · doi:10.1210/en.2003-0369 · Cited by 67
Postmenopausal osteoporosis, T cells, and immune dysfunction
Teitelbaum, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407335101 · Cited by 68
Postmenopausal Osteoporosis: A Literature Review
Bhatnagar, A., & Kekatpure, A. L. (2022) · Cureus · doi:10.7759/cureus.29367 · Cited by 79
Metadata
- Authors
- Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R.
- Affiliations
- Barnes-Jewish Hospital (US)
- Corresponding author
- Pacifici, Roberto
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-11-15
- Volume
- 106
- Issue
- 10
- Pages
- 1229-1237
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC381439
- OpenAlex
- W2133281510
- Cited by
- 705
- References
- 57
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 14 · 2023: 25 · 2022: 23 · 2021: 27 · 2020: 35 · 2019: 25 · 2018: 19 · 2017: 34 · 2016: 33 · 2015: 37 · 2014: 32 · 2013: 32 · 2012: 28
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Arthritis Foundation
- Eli Lilly and Company
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412, AR-13534)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- estrogen deficiency, bone loss, ovariectomy, T cells, TNF-α, osteoclastogenesis, RANKL, macrophage colony-stimulating factor, TNF receptor p55, postmenopausal osteoporosis, bone resorption, nude mice, estrogen receptor, mesenchymal stem cells, T cell deficiency
- MeSH terms
- Animals, Bone Resorption, Carrier Proteins, Cells, Cultured, Estrogens, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Nude, Osteoclasts, Ovariectomy, T-Lymphocytes, Tumor Necrosis Factor-alpha, Antigens, CD, Macrophage Colony-Stimulating Factor, Receptors, Tumor Necrosis Factor, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
